Chan C - Search Results

1

Peptoid inhibition of trypanothione reductase as a potential antitrypanosomal and antileishmanial drug lead.

Chan C, Yin H, McKie JH, Fairlamb AH, Douglas KT. Chan C, et al. Amino Acids. 2002 Jun;22(4):297-308. doi: 10.1007/s007260200016. Amino Acids. 2002. PMID: 12107758

2

Inhibitors of trypanothione reductase as potential antitrypanosomal drugs.

Chan C, Yin H, Garforth J, McKie JH, Jaouhari RA, Douglas KT, Fairlamb AH, Croft SL. Chan C, et al. Biochem Soc Trans. 1995 Nov;23(4):511S. doi: 10.1042/bst023511s. Biochem Soc Trans. 1995. PMID: 8654696 No abstract available.

3

Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.

Chan C, Yin H, Garforth J, McKie JH, Jaouhari R, Speers P, Douglas KT, Rock PJ, Yardley V, Croft SL, Fairlamb AH. Chan C, et al. J Med Chem. 1998 Jan 15;41(2):148-56. doi: 10.1021/jm960814j. J Med Chem. 1998. PMID: 9457238

4

Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines.

Khan MO, Austin SE, Chan C, Yin H, Marks D, Vaghjiani SN, Kendrick H, Yardley V, Croft SL, Douglas KT. Khan MO, et al. Among authors: chan c. J Med Chem. 2000 Aug 10;43(16):3148-56. doi: 10.1021/jm000156+. J Med Chem. 2000. PMID: 10956223

5

Specific peptide inhibitors of trypanothione reductase with backbone structures unrelated to that of substrate: potential rational drug design lead frameworks.

McKie JH, Garforth J, Jaouhari R, Chan C, Yin H, Besheya T, Fairlamb AH, Douglas KT. McKie JH, et al. Among authors: chan c. Amino Acids. 2001;20(2):145-53. doi: 10.1007/s007260170055. Amino Acids. 2001. PMID: 11332449

6

Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.

McKie JH, Douglas KT, Chan C, Roser SA, Yates R, Read M, Hyde JE, Dascombe MJ, Yuthavong Y, Sirawaraporn W. McKie JH, et al. Among authors: chan c. J Med Chem. 1998 Apr 23;41(9):1367-70. doi: 10.1021/jm970845u. J Med Chem. 1998. PMID: 9554869

7

Reversible time-dependent inhibition of cytochrome P450 enzymes by duloxetine and inertness of its thiophene ring towards bioactivation.

Chan CY, New LS, Ho HK, Chan EC. Chan CY, et al. Toxicol Lett. 2011 Oct 30;206(3):314-24. doi: 10.1016/j.toxlet.2011.07.019. Epub 2011 Aug 5. Toxicol Lett. 2011. PMID: 21839818

8

Effect of a calcium-channel blocker and β-blocker combination on reading-to-reading blood pressure variability: a randomized crossover trial.

Xia JH, Cheng YB, Xu TY, Guo QH, Chan CM, Hu LX, Li Y, Wang JG. Xia JH, et al. Among authors: chan cm. Blood Press Monit. 2024 Nov 26. doi: 10.1097/MBP.0000000000000736. Online ahead of print. Blood Press Monit. 2024. PMID: 39831760

9

Acute Sophora alkaloid poisoning in Hong Kong.

Chow TK, Kin Lam RP, Chan CK, Tse ML, Feng Y, Rainer TH. Chow TK, et al. Among authors: chan ck. Toxicon. 2025 Jan 15:108251. doi: 10.1016/j.toxicon.2025.108251. Online ahead of print. Toxicon. 2025. PMID: 39824462 Free article.

10

Multicenter Retrospective Analysis of Pediatric Differentiated Thyroid Carcinoma: Treatment Practices and Outcomes Prior to Pediatric American Thyroid Association Guidelines Implementation.

Mahajan P, May SB, Shekar M, Werny D, Patterson BC, Chan CM, Aldrink JH, Horvath KZ, Hawkins DS, Olson TA, Venkatramani R. Mahajan P, et al. Among authors: chan cm. Pediatr Blood Cancer. 2025 Jan 16:e31545. doi: 10.1002/pbc.31545. Online ahead of print. Pediatr Blood Cancer. 2025. PMID: 39821955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,189 results

Search Page

Filters